References
- Giona F., Testi A. M., Amadori S., Meloni G., Carotenuto M., Resegotti L., Colella R., Leoni P., Carella A. M., Grotto P., Miniero R., Mandelli F. Idarubicin and high-dose cytarabine in the treatment of refractory and relapsed acute lymphoblastic leukemia. Annals of Oncology 1990; 1: 51–55
- Giona F., Testi A. M., Annino L., Amadori S., Arcese W., Camera A., Cordero Di Montezemolo L., Ladogana S., Liso V., Meloni G., Moleti M. L., Rondelii R., Zanesco L., Pession A., Mandelli F. Treatment of primary refractory and relapsed acute lymphoblastic leukemia in children and adults: the GIMEMA/AIEOP experience. British Journal of Haematology 1994; 86: 55–61
- Kaplan E L, Meier P. Non-parametric estimation from incomplete observations. Journal of the American Statistical Association 1958; 53: 457–481
- Peto R., Peto J. Asymptotically efficient rank invariant test procedures. Journal of the Royal Statistical Society (A) 1972; 13: 185–198
- Cox D R. Regression models and life-tables (with discussion). Journal of the Royal Statistical Society (B) 1972; 34: 187–220
- Siegel S. Non-parametric statisyics for the behavioural sciences. 2nd Edn. McGraw Hill, New York 1988
- Tutschka P J, Copelan E A, Klein J P. Bone marrow transplantation for leukemia following a new busulphan and cyclophosphamide regimen. Blood 1987; 7: 1382–1388
- Meloni G., De Fabritiis P, Pulsoni A., Sandrelli A., Giona F, Simone F, Mandelli F. Results of two different conditioning regimens followed by ABMT in refractory acute lymphoblastic leukemia. Haematologica 1989; 74: 67–70
- Arlin Z A, Feldman E, Kempin S., Ahmad T., Mittelman A., Savona S., Ascensao J., Baskid P., Sullivan P., Fuhur H. G., Mertelsmann R. Amsacrine with high-dose cytarabine is higly effective therapy for refractory and relapsed acute lymphoblastic leukemia in adults. Blood 1988; 52: 433–439
- Hiddemann W, Buchner Th, Heil G., Schumacher K., Diedrich H., Maschmeyer G., Ho A. D., Planker M., Ger-Ith-Stolzenburg H., Donhuijsen-Ant R., Hoelzer D. Treatment of refractory acute lymphoblastic leukemia in adults with high dose Cytosine Arabinoside and mitox-antrone (HAM). Leukemia 1990; 4: 637–640
- Visani G, Tosi P, Zinzani P L., Manfroi S., Ottaviani E., Cen-Acchi A., Carrara P., Clavio M., Gobbi M., Tura S. FLAG (Fludarabine, Cytarabine, G-CSF) as a second line therapy for acute lymphoblastic leukemia with myeloid antigen expression: in vitro and in vivo effects. European Journal of Haematology 1996; 56: 308–312